Citation: Kr. Hildebrand et al., EVALUATION OF A NOVEL PROSTATIC DRUG-DELIVERY CATHETER - EFFECTIVE TRANSURETHRAL DRUG-DELIVERY TO THE CANINE PROSTATE, The Journal of urology, 159(5), 1998, pp. 394-394
Authors:
FINKELSTEIN MB
HOUGHTON WC
HILDEBRAND KR
KAPLAN SA
Citation: Mb. Finkelstein et al., LOCAL-DELIVERY OF LIDOCAINE TO THE CANINE PROSTATE USING PRESSURE ANDIONTOPHORESIS WITH A NOVEL CATHETER SYSTEM, The Journal of urology, 159(5), 1998, pp. 425-425
Citation: Mb. Finkelstein et al., CYSTEINE CONJUGATE BETA-LYASE-CATALYZED BIOACTIVATION OF BROMINE-CONTAINING CYSTEINE S-CONJUGATES - STOICHIOMETRY AND FORMATION OF 2,2-DIFLUORO-3-HALOTHIIRANES, Chemical research in toxicology, 9(1), 1996, pp. 227-231
Authors:
LOCK EA
SANI Y
MOORE RB
FINKELSTEIN MB
ANDERS MW
SEAWRIGHT AA
Citation: Ea. Lock et al., BONE-MARROW AND RENAL INJURY ASSOCIATED WITH HALOALKENE CYSTEINE CONJUGATES IN CALVES, Archives of toxicology, 70(10), 1996, pp. 607-619
Citation: Mb. Finkelstein et al., METABOLISM OF [C-14] AND [S-35] S-(1,2-DICHLOROVINYL)-L-CYSTEINE IN THE MALE FISCHER-344 RAT, Drug metabolism and disposition, 23(1), 1995, pp. 124-128
Authors:
FINKELSTEIN MB
DEKANT W
KENDE AS
ANDERS MW
Citation: Mb. Finkelstein et al., ALPHA-THIOLACTONES AS NOVEL INTERMEDIATES IN THE CYSTEINE CONJUGATE BETA-LYASE-CATALYZED BIOACTIVATION OF BROMINE-CONTAINING CYSTEINE S-CONJUGATES, Journal of the American Chemical Society, 117(37), 1995, pp. 9590-9591
Authors:
FINKELSTEIN MB
VAMVAKAS S
BITTNER D
ANDERS MW
Citation: Mb. Finkelstein et al., STRUCTURE MUTAGENICITY AND STRUCTURE CYTOTOXICITY STUDIES ON BROMINE-CONTAINING CYSTEINE S-CONJUGATES AND RELATED-COMPOUNDS, Chemical research in toxicology, 7(2), 1994, pp. 157-163